+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

A case of TdT-positive B-cell acute lymphoblastic leukemia

A case of TdT-positive B-cell acute lymphoblastic leukemia

American Journal of Clinical Pathology 85(6): 735-738

The phenotypic marker profile of a patient with B-cell acute lymphoblastic leukemia (B-ALL) is described. The blast cells showed typical FAB L3 morphology, had the characteristic t(8;14) chromosomal abnormality, and were monoclonal in the expression of surface immunoglobulins. The clinical course of this patient is consistent with the poor prognosis described for B-ALL cases. Surface marker analysis identified cells positive for surface immunoglobulins, Ia-like antigen, common ALL-antigen, and terminal deoxynucleotidyl transferase. This marker profile shows immunologic characteristics of the two B-cell leukemia subtypes, pre-B-ALL and B-ALL. This "intermediate" immunologic phenotype might either be the result of an uncoupling of the sequential immunologic maturation processes or of an arrest of the cells at an intermediate stage between the two otherwise clearly defined leukemia subtypes, but closer to the typical B-ALL stage. This latter observation is supported by isoenzyme marker analysis, as the cells were negative for the hexosaminidase I isoenzyme, which is positive in pre-B-ALL but negative in B-ALL.

(PDF emailed within 0-6 h: $19.90)

Accession: 039031243

Download citation: RISBibTeXText

PMID: 3518406

DOI: 10.1093/ajcp/85.6.735

Related references

Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181). Journal of Cellular Physiology 166(3): 618-630, 1996

Development of BCR-ABL positive acute lymphoblastic leukemia in donor cells after allogeneic hematopoietic cell transplantation for Philadelphia-positive acute lymphoblastic leukemia. Bone Marrow Transplantation 34(2): 189-191, 2004

Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies. Haematologica 103(1): 107-115, 2017

The first case of elderly TCF3-HLF-positive B-cell acute lymphoblastic leukemia. Leukemia and Lymphoma 2019: 1-4, 2019

Diagnostic challenges in T-lymphoblastic lymphoma, early T-cell precursor acute lymphoblastic leukemia or mixed phenotype acute leukemia: A case report. Medicine 97(41): E12743, 2018

MLL/GAS7 fusion in a pediatric case of t(11;17)(q23;p13)-positive precursor B-cell acute lymphoblastic leukemia. Haematologica 91(9): 1287-1288, 2006

Philadelphia chromosome positive pre-T cell acute lymphoblastic leukemia: a rare case report and short review. Indian Journal of Hematology and Blood Transfusion 30(Suppl 1): 177-179, 2014

Philadelphia positive acute lymphoblastic leukemia 16 years after the apparent cure of acute lymphoblastic leukemia. New leukemia or late relapse?. Haematologica 83(9): 855-856, 1998

Phenotypic switch in a Philadelphia-positive acute myeloid leukemia relapsing to acute lymphoblastic leukemia Case report. Blood 96(11 Part 2): 207b, November 16, 2000

Congenital MLL-positive B-cell acute lymphoblastic leukemia (B-ALL) switched lineage at relapse to acute myelocytic leukemia (AML) with persistent t(4;11) and t(1;6) translocations and JH gene rearrangement. Leukemia and Lymphoma 46(8): 1223-1227, 2005

Persistent presence of common acute lymphoblastic leukemia antigen positive cells in regenerating bone marrow after cessation of maintenance therapy in acute lymphoblastic leukemia of childhood. European Paediatric Haematology & Oncology 2(4): 217-219, 1985

Two t(9;22) leukemia cell lines (NALM-24 and NALM-25) with bi-phenotypic characteristics and an EBV-positive B-cell non-leukemia cell line (B262) established from a patient with acute lymphoblastic leukemia. Human Cell 4(4): 339-342, 1991

A case of childhood T cell acute lymphoblastic leukemia with a complex t(9;9) and homozygous deletion of CDKN2A gene associated with a Philadelphia-positive minor subclone. Blood Cells, Molecules and Diseases 50(2): 131-133, 2013

Characterization of the CDR3 structure of the Vβ21 T cell clone in patients with P210(BCR-ABL)-positive chronic myeloid leukemia and B-cell acute lymphoblastic leukemia. Human Immunology 72(10): 798-804, 2012

Anti-CD19 chimeric antigen receptor T-cell therapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia: Two case reports. Medicine 95(51): E5676, 2017